Government Affairs
The Government Affairs Department provides a proactive and effective process through which H. D. Smith communicates and influences healthcare policy with state and federal government officials. Through use of coalition building, strategic networking and lobbying efforts, we strive to foster policy that elevates the healthcare community.
Announcements
As the debate continues over the future direction of healthcare policy, H. D. Smith posts the most current and relevant information as it becomes available.
Federal Regulations and Legislation
The outcome of governmental initiatives impacts the way pharmaceutical products are manufactured, distributed and dispensed. Here you will find recent governmental developments on the Federal level.
- S. 3543: Medication Therapy Management Expanded Benefits Act 8/16/10
- H.R. 5710: The National All Schedules Prescription Electronic Reporting Reauthorization Act (NASPER) of 2010 8/12/10
- H.R. 5809: The Safe Drug Disposal Act of 2010 8/12/10
- H.R. 5888: America Rx Act of 2010 8/12/10
- S. 258: Saving Kids from Dangerous Drugs Act of 2010 8/12/10
State Regulations and Legislation
H. D. Smith also communicates regional developments to our valued customers. Provided below are several governmental proposals pending at the State level.
- Iowa 8/13/10
- Massachusetts 8/13/10
- Illinois 6/17/10
- New York 4/20/10
- New Hampshire 4/20/10
Contact the Government Affairs Department
Contact Government Affairs at 866.232.1222 or .